Piper Sandler Upgrades Exact Sciences (EXAS) to Overweight, 'A Good Entry Point, Without The Colonoscopy'
Tweet Send to a Friend
(Updated - October 10, 2023 4:43 AM EDT)
Piper Sandler analyst David Westenberg upgraded Exact Sciences (NASDAQ: EXAS) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Piper Sandler analyst David Westenberg upgraded Exact Sciences (NASDAQ: EXAS) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
